ATX-101 is a synthetic derivative from deoxycholic acid, which leads to destruction of adipocytes and to a skin retraction. The US Food and Drug Administration (FDA) has authorized ATX-101 injections for reduction of moderate to severe submental fat. The purpose of this note is to review the data of literature regarding the deoxycholic acid (ATX-101) where a significant difference for the submental fat between the treated group and the placebo group according to clinical and morphological criteria was observed (Refine Study 1 and 2). Side effects of this molecule seems to be limited.
Keywords: Acide désoxycholique; Deoxycholic acid; Lipolyse; Lipolysis; Liposuccion; Liposuction; Lypolyse; Sous-mentale; Submental.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.